3-甲基-1H-吡唑-4-胺 | 113140-10-6

• 物质功能分类: 有机原料 - 氨基化合物 - 环烷胺、芳香单胺、芳香多胺及其衍生物和盐
• 分子结构分类: 有机化合物 - 有机杂环化合物 - 唑类
• 中文名称: 3-甲基-1H-吡唑-4-胺
• 英文名称: 3-methyl-1H-pyrazol-4-amine
• 英文别名: 5-methyl-1H-pyrazol-4-amine
• CAS: 113140-10-6
• 化学式: C₄H₇N₃
• mdl: MFCD04969914
• 分子量: 97.1197
• InChiKey: WMEWGPRHFFHUAV-UHFFFAOYSA-N

物化性质

• 熔点：
  97 °C
• 沸点：
  309.4±22.0 °C(Predicted)
• 密度：
  1?+-.0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  -0.1
• 重原子数：
  7
• 可旋转键数：
  0
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.25
• 拓扑面积：
  54.7
• 氢给体数：
  2
• 氢受体数：
  2

安全信息

• 危险等级：
  IRRITANT
• 海关编码：
  2933199090
• 危险性防范说明：
  P261,P264,P270,P271,P280,P301+P312,P302+P352,P304+P340,P330,P363,P501
• 危险性描述：
  H302,H315,H319,H335

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: 3-Methyl-1H-pyrazol-4-amine
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

---

Section 3. Composition/information on ingredients.
Ingredient name: 3-Methyl-1H-pyrazol-4-amine
CAS number: 113140-10-6

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Storage: Store in closed vessels, refrigerated.

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
Melting point: No data
Flash point: No data
Density: No data
Molecular formula: C4H7N3
Molecular weight: 97.1

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

制备方法与用途

用途

3-甲基-1H-吡唑-4-胺是一种胺类衍生物，可用作医药中间体。

反应信息

• 作为反应物：
  描述：

  3-甲基-1H-吡唑-4-胺 、 4-正丁基苯酚异氰酸酯 在 三乙胺 作用下， 以 四氢呋喃 为溶剂， 反应 2.0h， 生成 1-(4-butylphenyl)-3-(5-methyl-1H-pyrazol-4-yl)urea
  参考文献：
  名称：

  WO2020010155A5

  摘要：

  公开号：

  WO2020010155A5
• 作为产物：
  描述：

  3-甲基-4-硝基吡唑 在 potassium tert-butylate 、 联硼酸频那醇酯 作用下， 以 甲醇 、 异丙醇 为溶剂， 反应 3.0h， 以3.8 g的产率得到3-甲基-1H-吡唑-4-胺
  参考文献：
  名称：

  [EN] PESTICIDAL PYRAZOLE AND TRIAZOLE DERIVATIVES
  [FR] DÉRIVÉS PYRAZOLÉS ET TRIAZOLÉS ANTIPARASITAIRES

  摘要：

  本发明涉及式(I)的化合物，以及其N-氧化物、立体异构体、互变异构体和农业或兽医可接受的盐，其中变量根据说明书中的定义。式(I)的化合物，以及其N-氧化物、立体异构体、互变异构体和农业或兽医可接受的盐，可用于对抗或控制无脊椎动物害虫，特别是节肢动物害虫和线虫。本发明还涉及一种利用这些化合物控制无脊椎动物害虫的方法，以及包括所述化合物的植物繁殖材料和农业和兽医组合物。

  公开号：

  WO2021013561A1

文献信息

• [EN] PESTICIDAL PYRAZOLE AND TRIAZOLE DERIVATIVES<br/>[FR] DÉRIVÉS PYRAZOLÉS ET TRIAZOLÉS ANTIPARASITAIRES
  申请人：BASF SE

  公开号：WO2021013561A1

  公开（公告）日：2021-01-28

  The present invention relates to the compounds of formula (I), and the N-oxides, stereoisomers, tautomers and agriculturally or veterinarily acceptable salts thereof wherein the variables are defined according to the description. The compounds of formula (I), as well as the N-oxides, stereoisomers, tautomers and agriculturally or veterinarily acceptable salts thereof, are useful for combating or controlling invertebrate pests, in particular arthropod pests and nematodes. The invention also relates to a method for controlling invertebrate pests by using these compounds and to plant propagation material and to an agricultural and a veterinary composition comprising said compounds.

  本发明涉及式(I)的化合物，以及其N-氧化物、立体异构体、互变异构体和农业或兽医可接受的盐，其中变量根据说明书中的定义。式(I)的化合物，以及其N-氧化物、立体异构体、互变异构体和农业或兽医可接受的盐，可用于对抗或控制无脊椎动物害虫，特别是节肢动物害虫和线虫。本发明还涉及一种利用这些化合物控制无脊椎动物害虫的方法，以及包括所述化合物的植物繁殖材料和农业和兽医组合物。
• [EN] TROPOMYOSIN-RELATED KINASE INHIBITORS CONTAINING BOTH A 1H-PYRAZOLE AND A PYRIMIDINE MOIETY<br/>[FR] INHIBITEURS DE KINASES APPARENTÉES À LA TROPOMYOSINE CONTENANT À LA FOIS UN 1H-PYRAZOLE ET UN FRAGMENT PYRIMIDINE
  申请人：PFIZER

  公开号：WO2015159175A1

  公开（公告）日：2015-10-22

  The present invention relates to compounds of Formula (I) and their prodrugs and pharmaceutically acceptable salts, wherein the substituents are as described herein, and their use in medicine, in particular as TrkA antagonists.

  本发明涉及式（I）化合物及其前药和药用可接受的盐，其中取代基如本文所述，并且它们在医学上的用途，特别是作为TrkA拮抗剂。
• ERK INHIBITORS
  申请人：Eli Lilly and Company

  公开号：US20160176896A1

  公开（公告）日：2016-06-23

  The present invention provides thieno[2,3-c]pyrrol-4-one compounds that inhibit activity of extracellular-signal-regulated kinase (ERK) and may be useful in the treatment of cancer.

  本发明提供了抑制细胞外信号调节激酶（ERK）活性的噻吩[2,3-c]吡咯-4-酮化合物，并可能在癌症治疗中有用。
• Copper-Catalyzed CNH₂Arylation of 2-Aminobenzimidazoles and Related C-Amino-NH-azoles
  作者：Desaboini Nageswar Rao、Sk. Rasheed、Karampoori Anil Kumar、Annem Siva Reddy、Parthasarathi Das

  DOI：10.1002/adsc.201600035

  日期：2016.6.30

  nucleophilic sites that are selectively arylated at the CNH2 position are obtained, providing an exceptional tool for rapid delivery of a diverse array of medicinally important CNH(aryl) derivatives of aminoazoles without any protection/deprotection of ring NH bonds. It is first example for the selective CNH2 arylation of 5‐aminoindazole, 4‐aminopyrazole, 5‐aminopyrazole, 9H‐purine‐6‐amine, and 1H‐pyrazolo[3

  的铜（II） -催化选择性Ç  NH 2的2-氨基苯并咪唑和露天的条件下在60℃下在2,2'-联吡啶和碳酸铯的存在下实现的相关C-氨基-NH-唑类芳基化，这为第一种方法的铜催化的选择性ç  NH 2的芳基化在其它反应性亲核位点的存在。以前未开发杂具有多个亲核部位被在C选择性芳基化 NH 2位置获得，为药用重要℃的不同阵列的快速递送一个特殊工具无任何保护/脱保护aminoazoles的NH（芳基）衍生物N环H键。它是用于选择性C首先例如 NH 2 5氨基吲唑，4-氨基吡唑，5-氨基吡唑，9的芳基化ħ嘌呤-6-胺和1- ħ -吡唑并[3,4- d ]嘧啶-4-胺衍生物。
• [EN] TROPOMYOSIN-RELATED KINASE INHIBITORS<br/>[FR] INHIBITEURS DE KINASES APPARENTÉES À LA TROPOMYOSINE
  申请人：PFIZER

  公开号：WO2015170218A1

  公开（公告）日：2015-11-12

  The present invention relates to compounds of Formula I and their pharmaceutically acceptable salts, wherein the substituents are as described herein, and their use in medicine, in particular as TrkA antagonists.

  本发明涉及式I化合物及其药用可接受的盐，其中取代基如本文所述，并且在医学上的应用，特别是作为TrkA拮抗剂。